Evidence map›Paper›PMID 10568752›Full record

ArticleGenome research1999

A genetic strategy to eliminate self-activator baits prior to high-throughput yeast two-hybrid screens.

A J Walhout, M Vidal

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Proteome-Scale Human Interactomics.Trends in biochemical sciences · 2017
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Gene-centered yeast one-hybrid assays.Methods in molecular biology (Clifton, N.J.) · 2012
    Article
  12. Article
  13. Gene-centered regulatory network mapping.Methods in cell biology · 2011
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

A J WalhoutMassachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129, USA.
M Vidal
Massachusetts General Hospital · US

Funding

The C. elegans Interactome ProjectR01HG001715 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI HILL, DAVID E., ROTH, FREDERICK P · 1998 to 2010
$16.5M
NHGRI NIH HHS 1 RO1 HG01715 A1NHGRI NIH HHS R01 HG001715
6 · The paper itself

Abstract

Large-scale sequencing projects have predicted high numbers of gene products for which no functional information is yet available. Hence, large-scale projects, such as gene knockouts, gene expression profiles, and protein-interaction mapping, are currently under way to initiate the understanding of the function of these gene products. The high-throughput strategies that are currently being developed to generate protein-interaction maps include automated versions of the yeast two-hybrid system. These strategies rely on the large-scale construction of DNA-binding domain/protein-of-interest hybrid constructs (DB-X baits). An inherent problem of large-scale two-hybrid systems is that a high percentage of cloned sequences encode polypeptides that, when fused to DB, can activate transcription in the absence of any two-hybrid-interacting partner protein. Here, we describe and validate a genetic strategy that efficiently eliminates such self-activator baits prior to screening procedures. The strategy is based on a negative-growth selection and is compatible with high-throughput settings.

Indexed as

Two-Hybrid System TechniquesDNA, FungalFungal ProteinsGene LibraryGenes, FungalSaccharomyces cerevisiaeSelection, GeneticTrans-ActivatorsDNA, FungalFungal ProteinsTrans-Activators

Identifiers

PMID10568752
PMCPMC544402
OpenAlexW2028872736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.